Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 10/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HSD17B2 | P37059 | 3/20 | 0.39 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.39 |
| ▸ | CNR1 | P21554 | 2/20 | 0.37 |
| ▸ | FNTA | P49354 | 1/20 | 0.37 |
| ▸ | FNTB | P49356 | 1/20 | 0.37 |
| ▸ | JAK2 | O60674 | 1/20 | 0.36 |
| ▸ | JAK3 | P52333 | 1/20 | 0.36 |
| ▸ | KDM1A | O60341 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15506435 | 0.83 | CNR2 (1.00) | CNR2ALDH1A1GAACNR1 | |
| SCHEMBL15516390 | 0.82 | CNR2 (1.00) | CNR2ALDH1A1GAACNR1 | |
| SCHEMBL15515039 | 0.79 | CNR2 (0.76) | CNR2CNR1FNTAFNTB | |
| SCHEMBL23198601 | 0.78 | CNR2 (0.79) | CNR2CNR1FNTAFNTB | |
| SCHEMBL17694501 | 0.77 | CNR2 (0.73) | CNR2CNR1FNTAFNTB | |
| SCHEMBL15517365 | 0.76 | CNR2 (1.00) | CNR2CNR1FNTAFNTB | |
| SCHEMBL3923273 | 0.76 | CNR2 (0.51) | CNR2HSD17B2HSD17B1CNR1 | |
| SCHEMBL15506433 | 0.75 | CNR2 (1.00) | CNR2ALDH1A1GAACNR1 | |
| SCHEMBL6275835 | 0.75 | CNR2 (0.61) | CNR2ALDH1A1GAAHSD17B2CNR1 | |
| SCHEMBL15515442 | 0.74 | CNR2 (1.00) | CNR2GAACNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210101878-A1 | Cannabinergic Compounds And Uses Thereof | NORTHEASTERN UNIVERSITY | 2021-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210101878-A1 | Cannabinergic Compounds And Uses Thereof | CNR2, CNR1, GPR18 | CNR2 1/4885ALDH1A1 2734/4885GAA 796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.